Roche Chairman Labels US Tariff Policy as Blackmail
Roche Chairman Severin Schwan criticized US tariff policies as blackmail. He identified US and Chinese protectionism as the firm's chief geopolitical concern.
Insights:
Roche Chairman Severin Schwan criticized United States tariff policies on June 4, describing a drug-pricing agreement as "cold-blooded blackmail." The comments follow a late-2023 deal to cut medicine prices after officials threatened 200% tariffs on drugmakers. The rhetoric highlights escalating geopolitical risks for European pharmaceutical firms operating in major global markets.
